CARLSBAD, Calif., May 12, 2022
/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today
announced that management will present at the RBC Capital Markets
Global Healthcare Conference on Wednesday,
May 18, 2022.
A live webcast and additional information about this
presentation can be accessed on the Investors & Media section
of the Ionis website at www.ionispharma.com. A replay will be
available on the Ionis website within 48 hours of each event.
About Ionis Pharmaceuticals, Inc.
For more than 30
years, Ionis has been the leader in RNA-targeted therapy,
pioneering new markets and changing standards of care with its
novel antisense technology. Ionis currently has three marketed
medicines and a premier late-stage pipeline highlighted by
industry-leading cardiovascular and neurological franchises. Our
scientific innovation began and continues with the knowledge that
sick people depend on us, which fuels our vision of becoming a
leading, fully integrated biotechnology company.
To learn more about Ionis visit www.ionispharma.com and
follow us on Twitter @ionispharma.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-rbc-capital-markets-global-healthcare-conference-301545318.html
SOURCE Ionis Pharmaceuticals, Inc.